Zynex, Inc. is a medical device company specializing in the development, manufacturing, marketing, and distribution of electrotherapy products for pain management, physical rehabilitation, neurological diagnosis, and cardiac monitoring. Founded in 1996 by Thomas Sandgaard, the company focuses on non-invasive technologies that reduce reliance on medications, enhance mobility, and improve patient outcomes through devices like NexWave, NeuroMove, InWave, E-Wave, and M-Wave, which utilize interferential current, neuromuscular electrical stimulation, transcutaneous electrical nerve stimulation, and electromyography. Zynex also offers monitoring solutions such as the CM-1500 and CM-1600 for fluid status, sepsis, and pulse oximetry in hospital settings, alongside complementary products including electrodes, batteries, back braces, and distributed items like Comfortrac. Headquartered in Englewood, Colorado, with approximately 1,000 employees, Zynex serves healthcare providers, hospitals, and patients worldwide, emphasizing high gross margins around 80% and steady revenue growth. Its innovations position it as a key player in the electrotherapy and medical monitoring sectors, supporting better quality of life for those with debilitating pain or functional disabilities.
See your Portfolio Score and get data driven insights in ~60 seconds.
Opens in PortfolioPilot
Based on technical indicators and chart patterns, ZYXIQ shows...
Market sentiment analysis indicates...